Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.

Biocidal product factsheet - Last updated: 19/06/2024

Biocidal Product details

Trade name:

Neutralac® Calci-flo Optilight

Neutralac® Q

Neutralac® Q1

Neutralac® Q2

Neutralac® Q2 DB

Neutralac® Q200

Neutralac® Q3

Neutralac® Q3-7

Neutralac® Q90

Neutralac® Q90 SR

Product-type:

PT02

Active Substance details

IUPAC name:

oxocalcium

EC number:

215-138-9

CAS number:

1305-78-8

BAS number:

1259

Authorised
map
Authorisation information
1 authorisation in the product cluster
Authorisation number SPC Decisions

Neutralac® Calci-flo Optilight

Neutralac® Q

Neutralac® Q1

Neutralac® Q2

Neutralac® Q2 DB

Neutralac® Q200

Neutralac® Q3

Neutralac® Q3-7

Neutralac® Q90

Neutralac® Q90 SR

PT02

Austria

Belgium

Bulgaria

Croatia

Cyprus

Czech Republic

Denmark

Estonia

Finland

France

Germany

Greece

Hungary

Ireland

Italy

Latvia

Lithuania

Luxembourg

Malta

Netherlands

Poland

Portugal

Romania

Slovakia

Slovenia

Spain

Sweden

Lhoist EU-0029494-0000 EU-0029494-0000 19/06/2024 30/11/2033

Single SPC  (it)

R4BP_EU_0029494_0000_Authorisation.pdf (en)

Authorised
Union authorisation
Trade name: Neutralac® Calci-flo Optilight , Neutralac® Q , Neutralac® Q1 , Neutralac® Q2 , Neutralac® Q2 DB , Neutralac® Q200 , Neutralac® Q3 , Neutralac® Q3-7 , Neutralac® Q90 , Neutralac® Q90 SR
Authorisation number: EU-0029494-0000| Market area: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden

1 assessment record available

Union authorisation

Evaluating authority:

ECHA

Conclusion date:

31/05/2024

Validity of authorisation

Start date:

19/06/2024

End date:

30/11/2033

SPC

Single SPC  (da)